- Federal agenciesEnables faster federal prosecution of novel fentanyl analogues by pre-listing a broad chemical class.
- Potential benefitSimplifies enforcement by reducing the time and analysis needed to classify emerging fentanyl derivatives.
- Potential benefitClarifies prohibited substances, likely increasing seizures and interdictions of illicit fentanyl analogues.
Stopping Overdoses of Fentanyl Analogues Act
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for co…
This bill amends the Controlled Substances Act to add a broad class of "fentanyl-related substances" to Schedule I. It defines covered substances by a set of structural chemical modifications and treats them as analogues for criminal and import/export penalties without requiring additional proof.
Progressives emphasize research and decriminalization concerns
Relative to its intended legislative type, this bill is a clear substantive statutory change that directly amends the Controlled Substances Act to classify a broad class of fentanyl-related substances as Schedule I and to apply specified penalty provisions immediately upon enactment.
This bill amends the Controlled Substances Act to add a broad class of "fentanyl-related substances" to Schedule I.
It defines covered substances by a set of structural chemical modifications and treats them as analogues for criminal and import/export penalties without requiring additional proof.
The change takes effect one day after enactment.
Substantive but narrow enforcement proposal with limited fiscal impact; legal, scientific, and civil‑liberties objections lower chances, especially in Senate.
Relative to its intended legislative type, this bill is a clear substantive statutory change that directly amends the Controlled Substances Act to classify a broad class of fentanyl-related substances as Schedule I and to apply specified penalty provisions immediately upon enactment.
Progressives emphasize research and decriminalization concerns
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenCould criminalize legitimate pharmaceutical and academic research on chemically related compounds.
- Potential burdenMay chill harm-reduction activities like drug checking, testing, and distribution of testing supplies.
- Potential burdenBroad structural language raises risks of prosecutorial overreach and challenges to due process protections.
Why the argument around this bill splits.
Progressives emphasize research and decriminalization concerns
Supports efforts to reduce fentanyl overdoses but worries this bill expands Schedule I too broadly.
Concerned it will criminalize users and hinder legitimate medical or scientific research.
Views the bill as a practical law-enforcement response to a deadly public-health problem but sees drafting risks.
Would back it with clarifying amendments to protect research and avoid overreach.
Likely supportive as a strong enforcement measure against fentanyl trafficking.
Sees value in removing legal hurdles for prosecuting dangerous analogue manufacturers and importers.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Substantive but narrow enforcement proposal with limited fiscal impact; legal, scientific, and civil‑liberties objections lower chances, especially in Senate.
- How broadly courts would interpret the chemical definition
- Absent DOJ/DEA cost and enforcement impact estimates
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Progressives emphasize research and decriminalization concerns
Substantive but narrow enforcement proposal with limited fiscal impact; legal, scientific, and civil‑liberties objections lower chances, es…
Relative to its intended legislative type, this bill is a clear substantive statutory change that directly amends the Controlled Substances Act to classify a broad class of fentanyl-related substances as Schedule I and…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.